Grid Therapeutics Collaborates with Catalent to Develop the First Human-Derived Antibody for the Treatment of Cancer Posted on October 31, 2017, in News, Press Releases Read more
Grid Therapeutics Closes Series A Financing Posted on September 20, 2017, in News, Press Releases Read more
Grid Therapeutics Signs Exclusive License to Develop a Novel Immuno-Oncology Antibody Posted on August 28, 2017, in News, Press Releases Read more
Human antibody enhances medication and significantly increases the death of cancer cells Posted on July 3, 2017August 3, 2017, in News, Press Releases Read more
Human antibody bolsters cancer drug performance Posted on July 1, 2017August 3, 2017, in News, Press Releases Read more
New antibody appears to re-activate immune system in cancer therapy Posted on June 28, 2017August 3, 2017, in News, Press Releases Read more
Antibody appears to attack cancer cells, leaving other cells unscathed Posted on May 5, 2016August 3, 2017, in News, Press Releases Read more
Researchers develop human-derived antibody that appears to destroy cancer cells Posted on May 5, 2016August 3, 2017, in News, Press Releases Read more
This breakthrough cancer treatment could target deadly cells and CURE killer disease Posted on May 5, 2016August 8, 2017, in News, Press Releases Read more
